June 19, 2020 / 11:04 AM / 25 days ago

BRIEF-Dynavax Says First Participants Dosed In Trial For Clover's COVID-19 S-Trimer Vaccine Candidate

June 19 (Reuters) - Dynavax Technologies Corp:

* DYNAVAX ANNOUNCES FIRST PARTICIPANTS DOSED IN PHASE 1 CLINICAL TRIAL EVALUATING CLOVER BIOPHARMACEUTICALS’ COVID-19 S-TRIMER VACCINE CANDIDATE WITH CPG 1018 ADJUVANT

* DYNAVAX TECHNOLOGIES CORP - CLOVER EXPECTS TO ENROLL 150 HEALTHY ADULT AND ELDERLY PARTICIPANTS IN PHASE 1 STUDY

* DYNAVAX TECHNOLOGIES CORP - PRELIMINARY SAFETY AND IMMUNOGENICITY RESULTS EXPECTED IN AUGUST 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below